|
J Biol Chem, Vol. 275, Issue 6, 4225-4229, February 11, 2000
Structure of the Influenza C Virus CM2 Protein
Transmembrane Domain Obtained by Site-specific Infrared Dichroism and
Global Molecular Dynamics Searching*
Andreas
Kukol and
Isaiah T.
Arkin
From the Cambridge Center for Molecular Recognition, Department of
Biochemistry, University of Cambridge, 80 Tennis Court Road,
Cambridge CB2 1GA, United Kingdom
 |
ABSTRACT |
The 115-residue protein CM2 from
Influenza C virus has been recently characterized as a
tetrameric integral membrane glycoprotein. Infrared spectroscopy and
site-directed infrared dichroism were utilized here to determine its
transmembrane structure. The transmembrane domain of CM2 is
-helical, and the helices are tilted by = (14.6 ± 3.0)° from the membrane normal. The rotational pitch angle about the
helix axis for the 1-13C-labeled residues
Gly59 and Leu66 is = (218 ± 17)°, where is defined as zero for a residue pointing in the
direction of the helix tilt. A detailed structure was obtained from a
global molecular dynamics search utilizing the orientational data as an
energy refinement term. The structure consists of a left-handed
coiled-coil with a helix crossing angle of = 16°. The
putative transmembrane pore is occluded by the residue
Met65. In addition hydrogen/deuterium exchange experiments
show that the core is not accessible to water.
 |
INTRODUCTION |
The virus Influenza is known from the past till today
as the causative agent of the most deadly disease outbreaks. Recently, the CM2 protein of Influenza C virus (1) has been
characterized as an integral membrane glycoprotein that forms disulfide
linked dimers and tetramers. Based on the overall topology containing a
23-residue extracellular part, a 23-residue membrane spanning part, and
a 69-residue cytoplasmic tail, CM2 is assumed to be structurally
similar to the Influenza A M2 protein and the
Influenza B NB protein (2, 3). The transmembrane domains of
M2 and NB both form ion channels in lipid membranes (4, 5), and the M2
H+ channel is blocked by the anti-Influenza drug
amantadine. Because these small viral membrane proteins form possible
targets for drugs, structural data may facilitate the development of
new antiviral drugs.
Because of the lack of high resolution x-ray data, molecular modeling
is commonly used to obtain structural models of transmembrane proteins
(6, 7). The M2 transmembrane domain has been a popular choice for
molecular modeling efforts (8, 9). We have applied the recently
developed method of site-directed infrared dichroism (10) to the M2
transmembrane domain resulting in orientational data (11), which is in
accordance with results obtained using solid state NMR (12). Further,
the orientational data were used in a global molecular dynamics search
to obtain a detailed structure that is in agreement with all functional
and mutagenesis data (11).
Here we present the first structural data about the CM2 transmembrane
domain. Initially, we characterized its secondary structure by infrared
spectroscopy and showed that it is mostly -helical. Subsequently,
the approach of site-directed infrared dichroism and molecular modeling
was used to determine the helix tilt, the relative orientation of the
helix within the helix bundle, and a detailed structure based on this orientation.
 |
MATERIALS AND METHODS |
Peptide Purification and Reconstitution--
Synthetic peptides
corresponding to the predicted transmembrane domain of the
Influenza C/Ann Arbor/1/150 virus CM2 sequence were made by
solid-phase Fmoc (N-(9-fluorenyl)methoxycarbonyl) chemistry,
cleaved from the resin with trifluoroacetic acid, and lyophilized. The
sequences corresponding to residues 47-76 (numbering includes a 24 residue signal peptide) are (2)
ENQGYMLTLASL([1-13C]G)LGIITM([1-13C]L)YLLVKIIIE
and
ENQGYMLTLASLGL([1-13C]G)IITMLY([1-13C]L)LVKIIIE,
each with two carbonyl 13C amino acids (Cambridge Isotopes
Laboratories, Andover, MA) at positions Gly59 and
Leu66 and at positions Gly61 and
Leu68, respectively. The peptides were further purified as
described elsewhere (11) for analogous transmembrane peptides. Briefly, the peptide was dissolved in trifluoroacetic acid and purified by
reversed phase high pressure liquid chromatography (Jupiter 5C4-300 Å column, Phenomenex, Cheshire, United Kingdom). Peptide elution was
achieved with a linear gradient to a final solvent composition of 5%
H2O, 20% trifluoroethanol, 28% acetonitrile, and 47%
2-propanol (Biocad Sprint, Perceptive Biosystems, Cambridge, MA). All
solvents contained 0.1% (v/v) trifluoroacetic acid. After lyophilization of pooled fractions, the peptide was reconstituted into
lipid vesicles by dialysis from a solution of 5% (w/v)
-octylglycopyranoside (Melford Laboratories, Ipswich, UK) and 12.5 mg/ml dimyristoylphosphocholine (Sigma) against 0.1 mM
phosphate buffer, pH 7 (11).
Infrared Spectroscopy--
Fourier transform infrared
(FTIR)1 spectra were recorded
on a Nicolet Magna 560 spectrometer (Nicolet, Madison, WI) equipped with a high sensitivity liquid nitrogen-cooled MCT/A detector. Attenuated total reflection-FTIR spectra were measured with a 25 reflections attenuated total reflection accessory from Graseby Specac
(Kent, UK) and a wire grid polarizer (0.25 µM, Graseby Specac). 200 µl of sample (~2.5 mg/ml protein and 12.5 mg/ml lipid) were dried onto a germanium trapezoidal internal reflection element (50 × 2 × 20 mm) under a stream of nitrogen. After
extensively purging the instrument with dry nitrogen, 1000 interferograms were averaged for every sample and processed with 1 point zero filling Happ-Genzel apodization. Transmission spectra were
obtained by drying 50 µl of sample on a CaF2 window with
a 15-mm diameter.
Fourier self-deconvolution (13) was applied to the spectra in the amide
I region to separate the overlapping 12C and
isotope-shifted 13C (14) amide I peaks. The enhancement
factor used in Fourier self-deconvolution was 2.0, and the half-height
bandwidth was 13 cm 1, as reported previously (15). The
dichroic ratio, R, was calculated as the ratio between the
integrated absorption of parallel and perpendicular polarized light of
the absorption bands (between 1670 and 1645 cm 1 for the
helix, 12C, and 1610 and 1630 cm 1 for the
site-specific label, 13C. The site-specific dichroic ratio,
Rsite, was corrected for the 1.1% natural
abundance 13C as described (11). D2O exchange
was performed by incubating the sample for 2 h in 99%
D2O before drying. To monitor the D2O exchange,
the amide II band between 1525 and 1570 cm 1 was
integrated, and its area AII was divided by the
total amide I area (y = AII/AI) to account for
differences in protein concentration. The amount of D2O
exchange was then calculated by dividing the corrected amide II area in
D2O (yD2O) by
the corrected amide II area in H2O
(yH2O).
Data Analysis--
The data were analyzed according to the
theory of site-specific dichroism presented in detail elsewhere (10)
with the extensions described (11). Briefly, the measured dichroic
ratio, the absorption ratio between parallel and perpendicular
polarized light R = A /A of a particular
transition dipole moment is a function of its spatial orientation. For
the amide I mode (mainly the C==O bond vibration) of an -helical
protein the geometric relation between the transition dipole moment and
the helix is known from fiber diffraction studies (16). Therefore, by
measuring the orientation of the amide I transition dipole one can
determine the helix tilt angle and the rotational pitch angle of the specific dipole moment about the helix axis. The rotational
pitch angle is arbitrarily defined as 0° when the transition
dipole moment, the helix director, and the z axis all reside
in a single plane. Thus, measuring the site-specific dichroic ratio
Rsite of the 13C amide I mode from a
particular label and the helix dichroic ratio
Rhelix allows calculation of the helix tilt and the rotational pitch angle of a particular label as detailed
previously (10), if measurements from two samples with labels at
different are analyzed together. Note that the difference of between two consecutive residues is assumed to be 100° as in a
canonical -helix (17). To enhance the 13C amide I mode
intensity we introduced two labels at position i and i + 7 assuming
that they posses the same as described elsewhere (18).
Molecular Modeling--
A global search with respect to rotation
about the helix axis, assuming tetrameric symmetry, was carried out as
described elsewhere in detail (11, 19). In brief, all calculations were performed with the parallel processing version of the Crystallography and NMR System (Version 0.3) (20) using the OPLS parameter set with a
united atom topology that explicitly represents the polar hydrogen and
aromatic side chain atoms (21). All calculations were carried out
in vacuo with the initial coordinates of a canonical -helix (3.6 residues/turn). Symmetric tetramers were generated from
the sequence YMLTLASLGLGIITMLYLLV, acetylated at the N terminus, and
methylaminated at the C terminus by replicating the helix and rotating
it by 360°/4 around the center of the tetramer. An initial crossing
angle of 25° for left-handed and 25° for right-handed structures
was introduced by rotating the long helix axis with respect to the long
bundle axis. The symmetric search was carried out by applying a
rotation to all helices simultaneously between = 0° and
= 360° in 10° steps. Four trials were carried out for each
starting structure, using different initial random atom velocities in
each case at both right- and left-handed crossing angles yielding
36 × 4 × 2 equaling 288 structures. Each structure was
subjected to a simulated annealing and energy minimization protocol.
Clusters of similar structures were defined such that the root mean
square deviation of the coordinates between all structures within a
cluster was not larger than 1.2 Å; a cluster was formed by a minimum
of 12 structures. For each cluster an average structure was calculated,
energy was minimized, and then the structure was subjected to the same
simulated annealing protocol used in the systematic search.
Orientation Refinement--
To take into account the results
obtained from the site-directed dichroism analysis, we have
incorporated an orientation refinement energy term in all molecular
dynamics and energy minimization calculations as described elsewhere
(11). According to the experimental data, a helix tilt restraint was
applied. To account for the rotational pitch angle, four site-specific
dichroism restraints were applied by setting the angles between the
13C==O bonds of Gly59, Leu66,
Gly61, and Leu68 and the z axis to
those obtained from the experiment. These angles are a function of the
helix tilt , the rotational pitch angle (10). This restraint
causes structures that deviate from the experiment to be higher in
energy. The rotational pitch angles of the resulting structures were
determined from a geometric analysis with a self-written program.
 |
RESULTS AND DISCUSSION |
FTIR Measurements--
The transmission FTIR spectra of the CM2
peptide reconstituted in lipid vesicles (Fig.
1, A and B) are
indicative of an -helical structure. FTIR spectroscopy has become a
standard tool to determine the secondary structure of proteins (15),
and even subtle differences in helical conformations of
bacteriorhodopsin have been monitored (22, 23). Quantitative estimates
of the secondary structure may be obtained by curve-fitting individual
components contributing to the amide I absorption and assigning each
component to a certain type of secondary structure (15). The analysis
yields a total of 68% -helix, 28% unordered, and 3.4% structure, the latter of which we attribute to not properly
reconstituted peptide. This compares well with the 20-residue predicted
transmembrane part (2) comprising 69% of the synthesized 29-residue
peptide.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
Transmission FTIR spectra of the lipid
vesicle reconstituted CM2 peptide 13C labeled at
Gly59/Leu66. The amide I region
(A) and the same region after Fourier-self deconvolution
(B) show the decomposition of the absorption bands into
their components (dotted lines) obtained by fitting Gaussian
curves to the spectrum. The component of the 13C amide band
centered at 1617 cm 1 is not visible because it is
overlaid by the spectrum. The curvefit of the summed components is
identical to the spectrum. C, amide I and amide II regions
before (solid line) and after a 4-h incubation in
D2O (dotted line). The absorbance is normalized
to the integrated area of the amide I peak centered at 1658 cm 1.
|
|
To estimate the amount of protein that is not accessible to water and
therefore embedded in the membrane, the hydrogen/deuterium exchange was
measured using the amide II absorption band (Fig. 1C). The
amount of exchange after a 4-h incubation in D2O is 34% of
the total amide II absorption. This indicates that the transmembrane part consists of 19-20 residues that are not accessible to water.
The attenuated total reflection-FTIR spectra of the
[13C1]Gly59/Leu66-
and
[13C1]Gly61/Leu68-labeled
peptide shown in Fig. 2 are indicative of
a perpendicular orientation of the -helix relative to the membrane
plane, because the absorbance obtained with parallel polarized light is
more intense than the absorbance obtained with perpendicular polarized light. The dichroic ratios for the helix and the
13C-labeled sites averaged from seven different
measurements for each peptide are shown in Table
I. The order parameter S, used extensively in conventional infrared dichroism analysis (24), is a
measure of the average orientation of molecules. An order parameter of
S = 1 is indicative of an orientation perpendicular to the
membrane plane, whereas S = 0.5 indicates an orientation parallel to the membrane plane. The order parameters S calculated for
the helix and the lipid bilayer (Table I) are indicative of a well
ordered lipid bilayer with helices possessing a net trans-bilayer
orientation. The quantitative analysis of the helix and site-specific
dichroic ratios yielded a helix tilt angle = (14.6 ± 3.0)° and a rotational pitch angle
Gly59/Leu66 = (218 ± 17)° and
Gly61/Leu68 = (58 ± 17)°. Note that Gly61/Leu68 = Gly59/Leu66 + 200°, as in
canonical -helix (17).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 2.
Attenuated total reflection deconvoluted FTIR
spectra of the lipid vesicle reconstituted CM2 peptide 13C
labeled at Gly59/Leu66 (A and
B) or Gly61/Leu68
(C and D) obtained with parallel
(solid line) or perpendicular (dotted
line) polarized light. In B and D
the spectra of A and C are shown whereby the
absorbance is normalized to the amide I maximal intensity to show the
dichroism of the 13C amide I absorption band.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Measured dichroic ratios
Dichroic ratios for the helix Rhelix, the
13C-labeled site Rsite, and lipid asymmetric
stretching (CH2) modes Rlipid for the two
CM2 peptides. Also shown are the calculated lipid order parameters
Slipid = (3cos2 1)/2 (24), the
helix tilt angle , and the rotational pitch angle about the
helix axis.
|
|
Global Molecular Dynamics Search--
A model built using the
transmembrane sequence of CM2, YMLTLASLGLGIITMLYLLV, was subjected to a
molecular dynamics search protocol assuming a tetrameric symmetrical
helix bundle. The molecular dynamics calculations were carried out
applying the experimental constraints. The distribution of structures
as a function of the energy and the helix rotation parameter is
shown as a polar plot in Fig. 3. The arcs
represent the individual structures that are clustered into groups of
similar structures. From these clusters average structures were
calculated and the energy was minimized. They are shown as numbered
circles. The negative energy is given by the distance from the origin.
In Fig. 3 and Table II it can be seen that structure number 2 has the
lowest energy. Geometric analysis of the structures reveals that
structure 2 has a rotational pitch angle = 224° (Table
II), which is in excellent agreement with
the experimental value = (218 ± 17)°. It can be seen
from the helix crossing angle , that structure 2 forms a left-handed coiled helical bundle. Structure 11, which is right-handed, with = 197°, is the next closest to the experimental value but is ruled out not only because of the fact that it is outside the experimental error range, but it also has a much higher energy than the
left-handed structure 2. Accordingly, structure 2 was chosen as the
correct model for the CM2 transmembrane domain.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 3.
Energy of all structures obtained from the
global search protocol dependent on the helix rotation parameter
in polar format moving
counterclockwise. The arcs represent the
energy and of each final structure, whereas the arrows
designate the change of during the simulation from the starting
structure. The negative energy is measured as the distance from the
origin. Cluster averages are shown as circles connected by
azimuthal lines with the origin.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Parameters of the structures from the global search.
Energy E of each structure, number of structures considered for the
average, helix crossing angle , helix rotation parameter , and
rotational pitch angles
Gly59/Leu66,
Gly61/Leu68 are given. was
calculated by geometric analysis of the coordinate file. The angles are
averages over all four helices of a structure.
|
|
Structure Description and Biological Implications--
The
structure in Fig. 4 reveals a left-handed
coiled-coil tetramer where the residues Leu55,
Leu58, Met65, and Leu68 are
pointing toward the pore. The structure is tilted by 15° from the
membrane normal. The pore is occluded mainly by Met65 and
partially by Leu55 as it can be seen from the space filling
model in Fig. 5. This is in agreement
with the data from the deuterium exchange experiments, which revealed
that the transmembrane part is not accessible to water. By analogy to
the Influenza M2 virus proton channel it has been speculated
that CM2 has ion channel function as well (2). Based on our structural
model, this hypothesis can be supported if we assume a closed
conformation of this ion channel with Met65 forming part of
the gate. The closed conformation is very likely to be present in a
partly dehydrated lipid membrane, where it is assumed that the lipids
are in a gel phase compared with the more fluid liquid crystalline
phase present under in vivo conditions. To observe a
conformational change to the open conformation, a simulation time in
the order of milliseconds would be necessary possibly including the
lipid bilayer as well (25), which is not yet feasible with the current
speed of computers.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 4.
Ribbon diagrams of the CM2 transmembrane
structure shown from the N terminus from Tyr51 to
Val70 (top) and from the side
(bottom). The residues pointing into the center,
Leu55, Leu58, Met65, and
Leu68, are shown in a ball and stick display. The figure
was created with MOLSCRIPT (28).
|
|

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 5.
Slices of the CM2 transmembrane
structure. From top to bottom:
Tyr51-Ala56,
Ala56-Gly61,
Gly61-Leu66, and
Leu66-Val70. The figure was created with
MOLSCRIPT (28).
|
|
It is interesting to note that the hydrophilic residues
Thr54, Ser57, and Thr64 are not
lining the channel pore but are located at the outer surface. This is
in accordance with other ion channel structures forming mostly
hydrophobic pores, e.g. the K+ channel (26) or
the HIV-I virus vpu protein (18).
The N-terminal extracellular part forms a wide entrance with the first
constriction at Leu55 (Fig. 5). This entrance could be a
possible target for antiviral drugs blocking the channel as it is
assumed for amantadine in the Influenza M2 virus proton
channel (27).
 |
ACKNOWLEDGEMENT |
We thank Prof. Dennis Pederson and Dr. Jaume
Torres for carefully reading the manuscript.
 |
FOOTNOTES |
*
This work was supported by the Wellcome Trust and BBSRC.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 44 1223 766 048;
Fax: 44 1223 766 002; E-mail: sa232@cam.ac.uk.
 |
ABBREVIATIONS |
The abbreviation used is:
FTIR, Fourier
transform infrared.
 |
REFERENCES |
| 1.
|
Hongo, S.,
Sugawara, K.,
Nishimura, H.,
Muraki, Y.,
Kitame, F.,
and Nakamura, K.
(1994)
J. Gen. Virol.
75,
3503-3510[Abstract/Free Full Text]
|
| 2.
|
Pekosz, A.,
and Lamb, R. A.
(1997)
Virology
237,
439-451[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Hongo, S.,
Sugawara, K.,
Muraki, Y.,
Kitame, F.,
and Nakamura, K.
(1997)
J. Virol.
71,
2786-2792[Abstract]
|
| 4.
|
Duff, K. C.,
and Ashley, R. H.
(1992)
Virology
190,
485-489[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Sunstrom, N. A.,
Premkumar, L. S.,
Premkumar, A.,
Ewart, G.,
Cox, G. B.,
and Gage, P. W.
(1996)
J. Membr. Biol.
150,
127-132[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Sansom, M. S. P.
(1998)
Curr. Opin. Struct. Biol.
8,
237-244[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Sansom, M. S. P.,
Forrest, L. R.,
and Bull, R.
(1998)
Bioessays
20,
1-10[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Sansom, M. S.,
Kerr, I. D.,
Smith, G. R.,
and Son, H. S.
(1997)
Virology
233,
163-173[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Pinto, L. H.,
Dieckmann, G. R.,
Gandhi, C. S.,
Papworth, C. G.,
Braman, J.,
Shaughnessy, M. A.,
Lear, J. D.,
Lamb, R. A.,
and DeGrado, W. F.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
11301-11306[Abstract/Free Full Text]
|
| 10.
|
Arkin, I. T.,
MacKenzie, K. R.,
and Brunger, A. T.
(1997)
J. Am. Chem. Soc.
119,
8973-8190[CrossRef]
|
| 11.
|
Kukol, A.,
Adams, P. D.,
Rice, L. M.,
Brunger, A. T.,
and Arkin, I. T.
(1999)
J. Mol. Biol.
286,
951-962[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Kovacs, F. A.,
and Cross, T. A.
(1997)
Biophys. J.
73,
2511-2517[Medline]
[Order article via Infotrieve]
|
| 13.
|
Kauppinen, J. K.,
Moffatt, D. J.,
Mantsch, H. H.,
and Cameron, D. G.
(1982)
Appl. Spectrosc.
35,
271-276[CrossRef]
|
| 14.
|
Tadesse, L.,
Nazarbaghi, R.,
and Walters, L.
(1991)
J. Am. Chem. Soc.
113,
7036-7037[CrossRef]
|
| 15.
|
Byler, D. M.,
and Susi, H.
(1986)
Biopolymers
25,
469-487[CrossRef][Medline]
[Order article via Infotrieve],
|
| 16.
|
Tsuboi, M.
(1962)
J. Polym. Sci. Part D Macromol. Rev.
59,
139-153
|
| 17.
|
Pauling, L.,
Corey, R. B.,
and Branson, H. R.
(1951)
Proc. Natl. Acad. Sci. U. S. A.
37,
205-211[Free Full Text]
|
| 18.
|
Kukol, A.,
and Arkin, I. T.
(1999)
Biophys. J.
77,
1594-1601[Medline]
[Order article via Infotrieve]
|
| 19.
|
Adams, P. D.,
Arkin, I. T.,
Engelman, D. M.,
and Brunger, A. T.
(1995)
Nat. Struct. Biol.
2,
154-162[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Brunger, A. T.,
Adams, P. D.,
Clore, G. M.,
Gros, W. L. P.,
Grosse-Kunstleve, R. W.,
Jiang, J. S.,
Kuszewski, J.,
Nilges, M.,
Pannu, N. S.,
Read, R. J.,
Rice, L. M.,
Simonson, T.,
and Warren, G. L.
(1998)
Acta Crystallogr. Sect. D
54,
905-921[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Jorgensen, W.,
and Tirado-Rives, J.
(1988)
J. Am. Chem. Soc.
110,
1657-1666[CrossRef]
|
| 22.
|
Torres, J.,
Sepulcre, J.,
and Padros, E.
(1995)
Biochemistry
34,
16320-16326[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Cladera, J.,
Torres, J.,
and Padros, E.
(1996)
Biophys. J.
70,
2882-2887[Medline]
[Order article via Infotrieve]
|
| 24.
|
Braiman, M. S.,
and Rothschild, K. J.
(1988)
Annu. Rev. Biophys. Biophys. Chem.
17,
541-570[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Tieleman, D. P.,
Berendsen, H. J. C.,
and Sansom, M. S. P.
(1999)
Biophys. J.
76,
1757-1769[Medline]
[Order article via Infotrieve]
|
| 26.
|
Doyle, D. A.,
Cabral, J. M.,
Pfuetzner, R. A.,
Kuo, A.,
Gulbis, J. M.,
Cohen, S. L.,
Chait, B. T.,
and MacKinnon, R.
(1998)
Science
280,
69-77[Abstract/Free Full Text]
|
| 27.
|
Lamb, R. A.,
and Pinto, L. H.
(1997)
Virology
229,
1-11[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Kraulis, P. J.
(1991)
J. Appl. Crystalogr.
24,
946-950[CrossRef]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Betakova and A. J. Hay
Evidence that the CM2 protein of influenza C virus can modify the pH of the exocytic pathway of transfected cells
J. Gen. Virol.,
August 1, 2007;
88(8):
2291 - 2296.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|